| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Swim Across America Laboratory,* Departments of Surgery,¶ Medicine, and Pathology, Memorial-Sloan Kettering Cancer Center, New York and Columbia Genome Center, Columbia University, New York, New York
Adult soft tissue sarcomas are a heterogeneous group of tumors, including well-described subtypes by histological and genotypic criteria, and pleomorphic tumors typically characterized by non-recurrent genetic aberrations and karyotypic heterogeneity. The latter pose a diagnostic challenge, even to experienced pathologists. We proposed that gene expression profiling in soft tissue sarcoma would identify a genomic-based classification scheme that is useful in diagnosis. RNA samples from 51 pathologically confirmed cases, representing nine different histological subtypes of adult soft tissue sarcoma, were examined using the Affymetrix U95A GeneChip. Statistical tests were performed on experimental groups identified by cluster analysis, to find discriminating genes that could subsequently be applied in a support vector machine algorithm. Synovial sarcomas, round-cell/myxoid liposarcomas, clear-cell sarcomas and gastrointestinal stromal tumors displayed remarkably distinct and homogenous gene expression profiles. Pleomorphic tumors were heterogeneous. Notably, a subset of malignant fibrous histiocytomas, a controversialhistological subtype, was identified as a distinct genomic group. The support vector machine algorithm supported a genomic basis for diagnosis, with both high sensitivity and specificity. In conclusion, we showed gene expression profiling to be useful in classification and diagnosis, providing insights into pathogenesis and pointing to potential new therapeutic targets of soft tissue sarcoma.
This article has been cited by other articles:
 |
|
 |
|
  I. Matushansky, E. Hernando, N. D. Socci, T. Matos, J. Mills, M. A. Edgar, G. K. Schwartz, S. Singer, C. Cordon-Cardo, and R. G. Maki A Developmental Model of Sarcomagenesis Defines a Differentiation-Based Classification for Liposarcomas Am. J. Pathol., April 1, 2008; 172(4): 1069 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Singer, N. D. Socci, G. Ambrosini, E. Sambol, P. Decarolis, Y. Wu, R. O'Connor, R. Maki, A. Viale, C. Sander, et al. Gene Expression Profiling of Liposarcoma Identifies Distinct Biological Types/Subtypes and Potential Therapeutic Targets in Well-Differentiated and Dedifferentiated Liposarcoma Cancer Res., July 15, 2007; 67(14): 6626 - 6636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. H. C. Bramwell Controversies in Surgical Oncology: Routine Anthracycline-based Adjuvant Chemotherapy for Stage III Extremity Soft Tissue Sarcoma Ann. Surg. Oncol., April 1, 2007; 14(4): 1254 - 1256. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Gold, S. M. van der Zwan, M. Gonen, R. G. Maki, S. Singer, M. F. Brennan, C. R. Antonescu, and R. P. De Matteo Outcome of Metastatic GIST in the Era before Tyrosine Kinase Inhibitors Ann. Surg. Oncol., January 1, 2007; 14(1): 134 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Agaram, P. Besmer, G. C. Wong, T. Guo, N. D. Socci, R. G. Maki, D. DeSantis, M. F. Brennan, S. Singer, R. P. DeMatteo, et al. Pathologic and Molecular Heterogeneity in Imatinib-Stable or Imatinib-Responsive Gastrointestinal Stromal Tumors Clin. Cancer Res., January 1, 2007; 13(1): 170 - 181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Clark, C. Fisher, I. Judson, and J. M. Thomas Soft-Tissue Sarcomas in Adults N. Engl. J. Med., August 18, 2005; 353(7): 701 - 711. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
